Aflibercept Monotherapy versus Bevacizumab First for Diabetic Macular Edema: A Cost Analysis based on DRCR Protocol AC Results
Patel, Nimesh, Hasenin Al-Khersan, Nicolas Yannuzzi, James Lin, and William Smiddy. 2022. “Aflibercept Monotherapy versus Bevacizumab First for Diabetic Macular Edema: A Cost Analysis Based on DRCR Protocol AC Results”. Ophthalmol Retina.